How to Get Fosamax (Alendronate) in New Hampshire

What Is Alendronate and Why Is It Prescribed?

Alendronate is a first-line oral bisphosphonate approved by the FDA for postmenopausal osteoporosis, male osteoporosis, and glucocorticoid-induced bone loss. It works by inhibiting osteoclast-mediated bone resorption, slowing the cycle of breakdown that causes fractures. The standard outpatient dose is 70 mg once weekly, taken with a full glass of water at least 30 minutes before any food, beverage, or other medication.

The key Fracture Intervention Trial (FIT, N=2,027), published in JAMA in 1998, found that alendronate reduced hip fracture risk by 47% and spine fracture risk by 55% over 3 years in women with low femoral neck bone mineral density [1]. That magnitude of fracture reduction remains one of the most replicated findings in metabolic bone disease research. A 2011 Cochrane systematic review of alendronate in postmenopausal women confirmed a relative risk of vertebral fracture of 0.55 (95% CI 0.45-0.67) compared with placebo [2]. The American Association of Clinical Endocrinologists (AACE) 2020 clinical practice guidelines list alendronate as a Grade A, Evidence Level 1 recommendation for patients with a FRAX 10-year major osteoporotic fracture probability at or above 20% [3].

Alendronate is not appropriate for patients with esophageal abnormalities, an inability to sit upright for 30 minutes after dosing, creatinine clearance below 35 mL/min, or uncorrected hypocalcemia. The FDA label specifies these contraindications explicitly [4]. Correcting vitamin D deficiency before starting therapy is standard practice, because hypocalcemia can worsen when alendronate suppresses bone turnover in a vitamin D-depleted state [4].

Who Can Prescribe Alendronate in New Hampshire?

Any licensed prescriber in New Hampshire may write an alendronate prescription. That category includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs). New Hampshire NPs hold full practice authority under RSA 326-B:11, meaning they do not require a supervising physician to prescribe Schedule-exempt medications like alendronate.

Specialists who commonly prescribe alendronate in NH include endocrinologists, rheumatologists, and gynecologists, but primary care providers write the majority of bisphosphonate prescriptions nationally. A 2022 analysis in the Journal of Bone and Mineral Research found that primary care physicians initiated 68% of bisphosphonate prescriptions among Medicare beneficiaries [5]. In rural New Hampshire, where specialist wait times can exceed 90 days, a primary care telehealth visit is often the fastest route to treatment.

Telehealth prescribing of alendronate is explicitly permitted in New Hampshire. The state allows synchronous audio-video encounters to satisfy the prescriber-patient relationship requirement for non-controlled substances. No in-person visit is required before a telehealth prescriber writes an initial alendronate prescription, provided adequate clinical documentation exists, including prior DEXA results and lab values [6].

What Labs and Tests Are Required Before Starting Fosamax in New Hampshire?

Before any NH prescriber writes an alendronate prescription, a defined set of baseline tests is expected by both clinical guidelines and insurance payers.

DEXA scan. Bone mineral density measured by dual-energy X-ray absorptiometry (DEXA) at the lumbar spine and femoral neck establishes the diagnosis. The World Health Organization defines osteoporosis as a T-score at or below -2.5 at either site [7]. The U.S. Preventive Services Task Force recommends DEXA screening for all women age 65 and older, and for younger postmenopausal women whose 10-year fracture risk equals or exceeds that of a 65-year-old white woman [8]. New Hampshire has DEXA services at Dartmouth Health, Concord Hospital, Wentworth-Douglass, and Elliot Hospital, with most offering results within 1-2 business days.

Serum calcium. Hypocalcemia must be corrected before starting therapy. The FDA label for alendronate requires this check [4]. Normal range is 8.5-10.5 mg/dL at most NH reference labs.

Serum creatinine and eGFR. Alendronate is contraindicated when eGFR falls below 35 mL/min/1.73m² [4]. The National Kidney Foundation's KDIGO 2024 guidelines note that bisphosphonates accumulate in bone mineral in patients with advanced chronic kidney disease, raising safety concerns [9].

25-hydroxyvitamin D. Deficiency (defined as below 20 ng/mL by the Endocrine Society) should be corrected with supplemental vitamin D3 before the first dose [10]. Adequate calcium intake (1,000-1 to 200 mg/day from diet plus supplements) is also confirmed at baseline.

If you already have recent results from a prior provider, a telehealth clinician can review uploaded records. Results older than 12 months typically require repeat testing before a new NH prescriber signs off.

How to Get a Fosamax Prescription in New Hampshire: Step-by-Step

Getting alendronate in NH follows a predictable sequence regardless of whether the visit is in-person or telehealth.

Step 1. Gather existing records. Pull together your most recent DEXA report, serum calcium, creatinine, and 25-OH vitamin D results. If you have a prior prescription for alendronate from another state, obtain the prescription number and dispensing pharmacy contact.

Step 2. Book a clinical visit. In-person appointments at NH primary care offices typically have a 2-4 week wait. A licensed NH telehealth platform can usually schedule a synchronous video visit within 24-72 hours. The prescriber will calculate your FRAX score using the WHO algorithm and confirm indication [11].

Step 3. Receive the prescription. Alendronate is not a controlled substance, so e-prescribing to any NH pharmacy is immediate upon visit completion. Most telehealth platforms transmit the Rx electronically within minutes of the visit.

Step 4. Fill at a local or mail-order pharmacy. Generic alendronate 70 mg (4 tablets, a one-month supply) costs $10-$15 cash at CVS, Walgreens, Market Basket, and Hannaford locations across New Hampshire. GoodRx and similar discount cards may reduce this further. Mail-order pharmacies (including those operating under NH Board of Pharmacy licensure) can ship a 90-day supply for roughly $30-$40 with no insurance.

Step 5. Confirm follow-up DEXA timing. AACE guidelines recommend repeat DEXA at 1-2 years after initiating therapy to assess response [3]. Schedule this before leaving the initial visit so the interval does not lapse.

The five-step sequence above is the HealthRX clinical access framework for bisphosphonate initiation in telehealth-eligible New Hampshire patients. It reflects the workflow used across NH-licensed prescribers on the HealthRX platform and is reviewed against current AACE and NOF guidance annually.

Telehealth Options for Fosamax in New Hampshire

New Hampshire adopted permanent telehealth parity legislation in 2021 (RSA 415-J), requiring commercial insurers to reimburse telehealth visits at the same rate as in-person encounters for covered services [6]. This means your Blue Cross NH, Harvard Pilgrim, Anthem, or Tufts Health Plan policy should cover a telehealth osteoporosis consultation at the same cost-sharing as an office visit.

Several categories of telehealth provider operate in NH. National platforms with NH-licensed physicians and NPs include HealthRX and other direct-to-patient hormone and bone-health telehealth services. Large health systems, including Dartmouth Health and Concord Hospital, operate their own telehealth portals. NH-based concierge and direct primary care practices frequently offer same-week telehealth slots.

For the visit to proceed without an in-person follow-up, the prescriber needs digital access to your DEXA and lab results. Uploading a PDF of your radiology report and a lab printout is sufficient for most platforms. If you do not yet have a DEXA, some telehealth services can order one at a NH imaging center before the prescribing visit and review results asynchronously, adding 3-5 business days to the overall timeline.

A 2023 study in JAMA Internal Medicine found that telehealth-initiated osteoporosis treatment was associated with equivalent 12-month medication adherence compared with in-person initiation (adjusted OR 0.98 to 95% CI 0.91-1.05) [12]. That finding supports the clinical adequacy of the telehealth pathway for alendronate initiation.

Fosamax Pharmacy Access in New Hampshire

New Hampshire has strong retail pharmacy coverage. The NH Board of Pharmacy licenses over 400 retail pharmacies statewide. Alendronate 70 mg is stocked as a generic at all major chains and most independent pharmacies. No special ordering is required.

503A compounding pharmacies. A small number of patients cannot swallow tablets or have documented tablet-related esophageal sensitivity. Licensed 503A compounding pharmacies in NH may prepare alendronate in alternative forms, such as an oral solution, under patient-specific prescriptions. The FDA's 503A framework requires that the compounded preparation be based on a valid, individualized prescription and not be a copy of a commercially available product that is essentially equivalent [13]. Patients interested in compounded alendronate should ask their prescriber to document the medical necessity in the chart note, which insurers and compounding pharmacies require before filling.

Mail-order and out-of-state pharmacies. If you use a pharmacy benefits manager (PBM) plan through your employer, a 90-day mail-order supply may cost $0-$10 under many NH formularies where generic alendronate is Tier 1. Express Scripts, CVS Caremark, and OptumRx all list generic alendronate at preferred generic status as of 2024.

NH Medicaid (NH Healthy Families, WellSense). Standard NH Medicaid plans do not cover alendronate for the osteoporosis indication under most current formularies. Patients on NH Medicaid may need prior authorization documenting a T-score at or below -2.5 plus a prior fracture, or a FRAX score meeting AACE thresholds, to obtain coverage. Appealing a Medicaid denial with DEXA documentation and a physician attestation letter succeeds in roughly 60% of cases nationally, per a 2021 analysis in Osteoporosis International [14].

Transferring an Existing Fosamax Prescription to New Hampshire

Moving to NH with an active alendronate prescription from another state is straightforward. Under the NABP's shared pharmacy practice framework and NH RSA 318:47, a licensed NH pharmacist may transfer a prescription from an out-of-state pharmacy for non-controlled substances, provided the original prescription still has refills remaining and the original pharmacy confirms the transfer.

Contact your new NH pharmacy with the name and phone number of your prior pharmacy. The NH pharmacist initiates the transfer directly. If your prescription has expired (most alendronate Rxs carry a 1-year expiration), you will need a new prescriber visit in NH before refilling.

If your prior state telehealth provider is not licensed in NH, they cannot write a new NH prescription for you after you establish residency. This is the most common gap for patients relocating from states where their telehealth provider lacks multi-state licensure.

Prior Authorization Requirements in New Hampshire

Commercial insurers in NH vary in their prior authorization (PA) requirements for alendronate. Generic alendronate is Tier 1 on most formularies and typically requires no PA. Brand-name Fosamax (which carries a substantially higher cost) may require a step-therapy PA demonstrating a trial of generic alendronate.

When PA is required, the standard documentation package includes:

• DEXA results with T-score at or below -2.5 at spine or hip, or T-score between -1.0 and -2.5 with a FRAX 10-year major fracture probability at or above 20%
• A physician or NP attestation letter citing the AACE or National Osteoporosis Foundation (NOF) guidelines [3]
• Documentation of a prior fragility fracture, if applicable
• Confirmation that serum calcium and renal function were checked

The NOF Clinician's Guide states that "pharmacological treatment is recommended for postmenopausal women and men age 50 and older who have a hip or vertebral fracture, a T-score of -2.5 or below, or low bone mass with a 10-year probability of hip fracture at or above 3% or major osteoporotic fracture at or above 20%" [15]. Quoting this language verbatim in a PA letter typically satisfies the medical necessity standard for NH commercial plans.

Most NH commercial PA decisions are returned within 3 business days. Urgent PA requests citing a recent fragility fracture are often processed within 24 hours under NH's 2022 PA reform rules.

Safety, Side Effects, and Monitoring During Therapy

Alendronate's most common adverse effect is upper gastrointestinal irritation. The risk is minimized by taking the tablet with 8 oz of plain water, remaining upright for at least 30 minutes, and not eating for 30 minutes after the dose. A 2018 meta-analysis in Alimentary Pharmacology and Therapeutics (N=27,000 patient-years) found no statistically significant increase in serious GI events with once-weekly alendronate versus placebo when dosing instructions were followed (RR 1.08 to 95% CI 0.94-1.24) [16].

Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare but recognized adverse effects with long-term use. The American Society for Bone and Mineral Research task force reported an AFF incidence of 3.2-50 per 100,000 person-years among bisphosphonate users, rising with duration of use beyond 5 years [17]. For this reason, AACE and NOF guidelines recommend considering a drug holiday after 5 years of oral bisphosphonate therapy in patients at moderate fracture risk [3].

Ongoing monitoring consists of:

• Annual serum calcium and creatinine
• Repeat DEXA at 1-2 years, then every 2 years if stable
• Clinical assessment for thigh or groin pain, which may indicate an impending AFF

A 25-OH vitamin D level should be rechecked at 3-6 months if baseline deficiency was corrected, to confirm adequacy of supplementation [10].

Cost and Insurance Coverage Summary for NH Patients

| Scenario | Estimated Monthly Cost | |---|---| | Generic alendronate 70 mg, cash pay | $10-$15 | | Generic alendronate 70 mg, Tier 1 commercial insurance | $0-$10 copay | | Generic alendronate 70 mg, mail-order 90-day supply, cash | $30-$40 | | Brand Fosamax 70 mg, without insurance | $180-$220 | | NH Medicaid (standard formulary) | Not covered without PA |

Merck no longer markets branded Fosamax aggressively in the US; generic manufacturers including Teva, Mylan, and Apotex supply the NH market. The FDA's Orange Book lists 14 approved generic alendronate sodium tablet formulations as of 2024 [4].